World's Best Scientists 2026 revealed!
Sabine Tejpar

Sabine Tejpar

D-Index & Metrics

Medicine

D-Index
93
Citations
52724
World Ranking
10662
National Ranking
126

Sabine Tejpar publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sabine Tejpar sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 421 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sabine Tejpar D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sabine Tejpar sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sabine Tejpar is affiliated with KU Leuven in Belgium and has a significant research footprint primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans various subfields including Oncology, Molecular Biology, Cancer Research, Immunology, and Pathology and Forensic Medicine.

Key areas of focus in their research include:

  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Colorectal Cancer Treatments and Studies
  • Immune Cell Function and Interaction
  • Pancreatic and Hepatic Oncology Research
  • Single-cell and spatial transcriptomics

The scientist has contributed multiple papers to notable journals with research spanning from 2020 to 2022. Significant recent publications include:

  • Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer, 2020, Nature Genetics
  • A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling, 2020, Cell Research
  • Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer, 2022, Nature Genetics
  • Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages, 2021, Cell Research
  • Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity, 2021, Nature Communications

Frequent publication venues include bioRxiv (Cold Spring Harbor Laboratory), Journal of Clinical Oncology, Annals of Oncology, Nature Communications, and Nature Genetics, reflecting a broad dissemination of research in oncology and related fields.

Sabine Tejpar has collaborated extensively with other researchers, with frequent coauthors including Abhishek D. Garg, Diether Lambrechts, Sara Verbandt, Jenny Sprooten, and Yourae Hong. These collaborations highlight a network of expertise supporting their multidisciplinary research efforts.

Best Publications

  • Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.

    Eric Van Cutsem;Claus Henning Köhne;Erika Hitre;Jerzy Zaluski

  • The consensus molecular subtypes of colorectal cancer

    Justin Guinney;Rodrigo Dienstmann;Rodrigo Dienstmann;Xingwu Wang;Xingwu Wang;Aurélien De Reyniès

  • ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    E. Van Cutsem;A. Cervantes;R. Adam;A. Sobrero

  • Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

    Wendy De Roock;Bart Claes;David Bernasconi;Jef De Schutter

  • Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status

    Eric Van Cutsem;Claus Henning Köhne;István Láng;Gunnar Folprecht

  • KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

    W. De Roock;H. Piessevaux;J. De Schutter;M. Janssens

  • Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

    Arnaud D. Roth;Sabine Tejpar;Mauro Delorenzi;Pu Yan

  • Peutz–Jeghers syndrome: a systematic review and recommendations for management

    A. D. Beggs;A. R. Latchford;H. F. A. Vasen;G. Moslein

  • Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer

    Rodrigo Dienstmann;Louis Vermeulen;Justin Guinney;Scott Kopetz

  • Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer

    Eric Van Cutsem;Heinz Josef Lenz;Claus Henning Köhne;Volker Heinemann

  • Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

    Wendy De Roock;Derek J Jonker;Federica Di Nicolantonio;Andrea Sartore-Bianchi

  • Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

    Hans F A Vasen;Ignacio Blanco;Katja Aktan-Collan;Jessica P Gopie

  • A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4).

    Carol J Gallione;Gabriela M Repetto;Eric Legius;Anil K Rustgi

  • Guidelines for the clinical management of familial adenomatous polyposis (FAP)

    H. F. A Vasen;G. Moslein;A. Alonso;S. Aretz

  • Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer Retrospective Analyses of the CRYSTAL and FIRE-3 Trials

    Sabine Tejpar;Sebastian Stintzing;Fortunato Ciardiello;Josep Tabernero

  • KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer

    Wendy De Roock;Veerle De Vriendt;Nicola Normanno;Fortunato Ciardiello

  • Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features.

    E. Missiaglia;B. Jacobs;G. D'Ario;A.F. Di Narzo

  • Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus.

    René Adam;Aimery de Gramont;Joan Figueras;Norihiro Kokudo

  • KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience

    E. Van Cutsem;I. Lang;G. D'haens;V. Moiseyenko

  • A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling.

    Junbin Qian;Siel Olbrecht;Bram Boeckx;Hanne Vos

Frequent Co-Authors

Mauro Delorenzi
Mauro Delorenzi University of Lausanne
Fortunato Ciardiello
Fortunato Ciardiello University of Campania "Luigi Vanvitelli"
Fred T. Bosman
Fred T. Bosman University of Lausanne
Bart Jacobs
Bart Jacobs Radboud University
Josep Tabernero
Josep Tabernero Vall d´Hebron Institute of Oncology
Pierre Laurent-Puig
Pierre Laurent-Puig Université Paris Cité
Heinz-Josef Lenz
Heinz-Josef Lenz University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always follow the traditional medical degree route. There are a variety of rn to bsn online no clinicals accredited programs available, making it possible for working registered nurses to advance their credentials without required hands-on clinical components.

For those interested in doctoral-level nursing, flexibility and speed matter. Consider the options for the fastest online dnp programs to quickly complete your Doctor of Nursing Practice while balancing career and personal commitments.

Academic rigor in doctoral programs can also be managed through dnp programs without dissertation, which streamline graduation requirements by eliminating the traditional dissertation project.

Aspiring nurses eager to enter the workforce rapidly should explore fast track lpn programs online. These programs offer accelerated pathways to becoming a Licensed Practical Nurse, supporting quicker entry into healthcare roles.

Each pathway offers unique opportunities for career advancement in medicine, catering to diverse learning styles, career goals, and time constraints. Carefully compare your options to find the best fit for your aspirations.

Best Scientists Citing Sabine Tejpar

Trending Scientists

Recently Published Articles